-
Ferring announces full availability of ADSTILADRIN® (nadofaragene firadenovec-vncg) in the U.S.
in PRESS RELEASE 2024 on…
-
Ferring and PharmaBiome enter into a new microbiome R&D collaboration and exclusive licensing agreement
in PRESS RELEASE 2023 onFerring and PharmaBiome enter into a new microbiome R&D collaboration and exclusive…
-
New data show durable response following treatment with ADSTILADRIN® (nadofaragene firadenovec-vncg)
in PRESS RELEASE 2023 on…
-
-
Royalty Pharma and Ferring Pharmaceuticals enter into US $500 million royalty agreement for new intravesical gene therapy Adstiladrin® (nadofaragene firadenovec-vncg)
in PRESS RELEASE 2023 on -
Ferring Pharmaceuticals appoints new Executive Chairman among key changes to Board of Directors
in PRESS RELEASE 2023 onAd hoc announcement pursuant to Art. 53 LR Ferring Pharmaceuticals appoints new…
-
Ferring Pharmaceuticals successfully increases its second Swiss Franc Bond offering by CHF 80 million
in STATEMENT 2023 onAd hoc announcement pursuant to Art. 53 LR Ferring Pharmaceuticals successfully increases…
-
Four Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, Presented at DDW 2023
in PRESS RELEASE 2023 onFour Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm), the…
-
Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in women’s health
in PRESS RELEASE 2023 onFerring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in…
-
Ferring Pharmaceuticals successfully launches its second Swiss Franc Bond offering for CHF 410 million
in STATEMENT 2023 onAd hoc announcement pursuant to Art. 53 LR Ferring Pharmaceuticals successfully launches…
Author archive for celia
Articles by: celia
